Journal Article Summary
The article investigates the risk of impulse control disorders (ICDs) in patients with Parkinson's disease (PD) who are treated with specific medications, namely pramipexole (PPX) and ropinirole (ROP). These medications, while effective for managing motor symptoms of PD, have been linked to an increased likelihood of developing ICDs, which can include behaviors like compulsive gambling and shopping. Understanding the relationship between these medications and the risk of ICDs is crucial, as managing these side effects can be challenging and significantly impact patients' quality of life.
The study analyzed data from 935 PD patients who were prescribed PPX or ROP, focusing on whether the use of other medications—such as atypical antipsychotics (AAs), selective serotonin reuptake inhibitors (SSRIs), and glutamatergic modulators (GMs)—could reduce the risk of ICDs. The findings revealed that the use of GMs and SSRIs was actually associated with an increased risk of ICDs in these patients, with GMs showing a particularly high adjusted odds ratio. The results for AAs were inconclusive due to insufficient data, suggesting that these commonly used treatments for other types of ICDs may not be effective in this specific context.
The study has several limitations, including a potential underestimation of ICD prevalence due to reliance on diagnostic codes, which may not capture all cases. Additionally, the observational nature of the study means that confounding factors could influence the results. Patients and caregivers should discuss these findings with healthcare professionals, particularly regarding the management of PD and the risks associated with medications like PPX and ROP, as well as the implications of using SSRIs and GMs in this population.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Jeon Nakyung, Bortolato Marco, De Luca Vincenzo, De Luca Vincenzo, De Luca Vincenzo. What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson’s disease? A preliminary pharmacoepidemiologic study. PLoS ONE 2020. DOI: 10.1371/journal.pone.0227128. PMID: 31910240. PMCID: PMC6946157.
Featured Pill Pals Product
Ropinirole 0.25 mg Tablets --- 30 Count --- Generic for Requip --- SOLCO Pharma
Ropinirole 0.25 mg Tablets — 30 Count — Generic for Requip — SOLCO Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
